Huahai Pharmaceutical (600521.SH) announced that on April 17, 2024, the company completed the repurchase and actually repurchased the public...
Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) announced that on April 17, 2024, the company completed the repurchase and actually repurchased 7.023,600 shares of the company's shares, accounting for 0.4738% of the company's total share capital. The highest repurchase price was 15.79 yuan/share, the lowest repurchase price was 12.36 yuan/share, the average repurchase price was 14.24 yuan/share, and the total capital used was 99.926 million yuan (excluding transaction fees).